Hikma Pharmaceuticals PLC (LON:HIK) arrived out with its annually benefits very last 7 days, and we desired to see how the business is performing and what business forecasters believe of the company subsequent this report. Revenues of US$2.6b were being in line with forecasts, even though statutory earnings for each […]